Literature DB >> 22275358

Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors.

Luis E Gimenez1, Seunghyi Kook, Sergey A Vishnivetskiy, M Rafiuddin Ahmed, Eugenia V Gurevich, Vsevolod V Gurevich.   

Abstract

Arrestins are a small family of proteins that regulate G protein-coupled receptors (GPCRs). Arrestins specifically bind to phosphorylated active receptors, terminating G protein coupling, targeting receptors to endocytic vesicles, and initiating G protein-independent signaling. The interaction of rhodopsin-attached phosphates with Lys-14 and Lys-15 in β-strand I was shown to disrupt the interaction of α-helix I, β-strand I, and the C-tail of visual arrestin-1, facilitating its transition into an active receptor-binding state. Here we tested the role of conserved lysines in homologous positions of non-visual arrestins by generating K2A mutants in which both lysines were replaced with alanines. K2A mutations in arrestin-1, -2, and -3 significantly reduced their binding to active phosphorhodopsin in vitro. The interaction of arrestins with several GPCRs in intact cells was monitored by a bioluminescence resonance energy transfer (BRET)-based assay. BRET data confirmed the role of Lys-14 and Lys-15 in arrestin-1 binding to non-cognate receptors. However, this was not the case for non-visual arrestins in which the K2A mutations had little effect on net BRET(max) values for the M2 muscarinic acetylcholine (M2R), β(2)-adrenergic (β(2)AR), or D2 dopamine receptors. Moreover, a phosphorylation-deficient mutant of M2R interacted with wild type non-visual arrestins normally, whereas phosphorylation-deficient β(2)AR mutants bound arrestins at 20-50% of the level of wild type β(2)AR. Thus, the contribution of receptor-attached phosphates to arrestin binding varies depending on the receptor-arrestin pair. Although arrestin-1 always depends on receptor phosphorylation, its role in the recruitment of arrestin-2 and -3 is much greater in the case of β(2)AR than M2R and D2 dopamine receptor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22275358      PMCID: PMC3308753          DOI: 10.1074/jbc.M111.311803

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Crystal structure of cone arrestin at 2.3A: evolution of receptor specificity.

Authors:  R Bryan Sutton; Sergey A Vishnivetskiy; Justin Robert; Susan M Hanson; Dayanidhi Raman; Barry E Knox; Masahiro Kono; Javier Navarro; Vsevolod V Gurevich
Journal:  J Mol Biol       Date:  2005-11-02       Impact factor: 5.469

2.  The differential engagement of arrestin surface charges by the various functional forms of the receptor.

Authors:  Susan M Hanson; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

Review 3.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

4.  Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin.

Authors:  Susan M Hanson; Derek J Francis; Sergey A Vishnivetskiy; Elena A Kolobova; Wayne L Hubbell; Candice S Klug; Vsevolod V Gurevich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-17       Impact factor: 11.205

5.  The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain.

Authors:  Hang Shi; Raul Rojas; Juan S Bonifacino; James H Hurley
Journal:  Nat Struct Mol Biol       Date:  2006-05-28       Impact factor: 15.369

6.  Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells.

Authors:  Michelle Trester-Zedlitz; Al Burlingame; Brian Kobilka; Mark von Zastrow
Journal:  Biochemistry       Date:  2005-04-26       Impact factor: 3.162

7.  Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation.

Authors:  Cornelius Krasel; Moritz Bünemann; Kristina Lorenz; Martin J Lohse
Journal:  J Biol Chem       Date:  2005-01-05       Impact factor: 5.157

8.  Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling.

Authors:  Jihee Kim; Seungkirl Ahn; Xiu-Rong Ren; Erin J Whalen; Eric Reiter; Huijun Wei; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

9.  Phosphorylation-independent beta-arrestin translocation and internalization of leukotriene B4 receptors.

Authors:  Venkatakrishna R Jala; Wen-Hai Shao; Bodduluri Haribabu
Journal:  J Biol Chem       Date:  2004-11-23       Impact factor: 5.157

10.  Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.

Authors:  David J Vaughan; Ellen E Millman; Veronica Godines; Jacqueline Friedman; Tuan M Tran; Wenping Dai; Brian J Knoll; Richard B Clark; Robert H Moore
Journal:  J Biol Chem       Date:  2006-01-03       Impact factor: 5.157

View more
  46 in total

Review 1.  Synthetic biology with surgical precision: targeted reengineering of signaling proteins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2012-06-01       Impact factor: 4.315

2.  A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.

Authors:  Jianxin Hu; Matthew Stern; Luis E Gimenez; Lizzy Wanka; Lu Zhu; Mario Rossi; Jaroslawna Meister; Asuka Inoue; Annette G Beck-Sickinger; Vsevolod V Gurevich; Jürgen Wess
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

3.  Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes.

Authors:  Luis E Gimenez; Stefanie Babilon; Lizzy Wanka; Annette G Beck-Sickinger; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

Review 4.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

5.  Molecular mechanism of GPCR-mediated arrestin activation.

Authors:  Naomi R Latorraca; Jason K Wang; Brian Bauer; Raphael J L Townshend; Scott A Hollingsworth; Julia E Olivieri; H Eric Xu; Martha E Sommer; Ron O Dror
Journal:  Nature       Date:  2018-05-02       Impact factor: 49.962

Review 6.  G protein-coupled receptors--recent advances.

Authors:  Dorota Latek; Anna Modzelewska; Bartosz Trzaskowski; Krzysztof Palczewski; Sławomir Filipek
Journal:  Acta Biochim Pol       Date:  2012-12-18       Impact factor: 2.149

7.  Engineering visual arrestin-1 with special functional characteristics.

Authors:  Sergey A Vishnivetskiy; Qiuyan Chen; Maria C Palazzo; Evan K Brooks; Christian Altenbach; Tina M Iverson; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

8.  Enhanced phosphorylation-independent arrestins and gene therapy.

Authors:  Vsevolod V Gurevich; Xiufeng Song; Sergey A Vishnivetskiy; Eugenia V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

9.  Targeting individual GPCRs with redesigned nonvisual arrestins.

Authors:  Luis E Gimenez; Sergey A Vishnivetskiy; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

10.  Critical role of the central 139-loop in stability and binding selectivity of arrestin-1.

Authors:  Sergey A Vishnivetskiy; Faiza Baameur; Kristen R Findley; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2013-03-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.